Asymptomatic left ventricular systolic dysfunction in patients with severe aortic stenosis: characteristics and outcomes

J Am Coll Cardiol. 2012 Dec 4;60(22):2325-9. doi: 10.1016/j.jacc.2012.08.988. Epub 2012 Nov 1.

Abstract

Objectives: This study sought to determine the prevalence, characteristics, and outcomes of asymptomatic left ventricular (LV) systolic dysfunction in patients with severe aortic stenosis (AS).

Background: Management of asymptomatic patients with severe AS remains controversial. In these patients, LV systolic dysfunction, defined in the guidelines as ejection fraction <50%, is a Class I(C) indication for aortic valve replacement (AVR), but its prevalence is unknown.

Methods: A retrospective study of adults ≥40 years of age with severe valvular AS (peak velocity ≥4 m/s, mean gradient >40 mm Hg, aortic valve area [AVA] <1 cm(2), or AVA index <0.6 cm(2)/m(2)) from 1984 to 2010 was undertaken. Patients with prior cardiac surgery, severe coronary artery disease, or greater than moderate aortic regurgitation were excluded.

Results: Of 9,940 patients with severe AS, 43 (0.4%) patients had asymptomatic LV dysfunction. Age was 73 ± 14 years and 70% were male. Hypertension (78%) and LV hypertrophy (LV mass index 143 ± 36 g/m(2)) were characteristic. Fifty-three percent of these patients developed symptoms at 21 ± 19 months after diagnosis. During 7.5 ± 6.7-year follow-up, 5-year mortality was 48%. After multivariable adjustment, there was no survival advantage with AVR in asymptomatic, severe AS with LV dysfunction (p = 0.51).

Conclusions: In severe AS, the prevalence of asymptomatic LV systolic dysfunction is 0.4%. Despite an asymptomatic clinical status, patients with severe AS and LV ejection fraction <50% have a poor prognosis, with or without AVR.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aortic Valve Stenosis / epidemiology
  • Aortic Valve Stenosis / mortality*
  • Aortic Valve Stenosis / physiopathology
  • Asymptomatic Diseases / epidemiology
  • Asymptomatic Diseases / mortality*
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Heart Failure, Systolic / epidemiology
  • Heart Failure, Systolic / mortality*
  • Heart Failure, Systolic / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Severity of Illness Index*
  • Survival Rate / trends
  • Treatment Outcome
  • Ventricular Dysfunction, Left / epidemiology
  • Ventricular Dysfunction, Left / mortality*
  • Ventricular Dysfunction, Left / physiopathology